| Literature DB >> 15030767 |
Abstract
Cytokine-mediated inflammation is a target for novel therapies as well as for fundamental research. A single amino acid mutation in the NALP-3 gene controlling the activation of caspase-1 results in increased processing of the inactive IL-1beta precursor and release of the active cytokine. Blocking IL-1 receptors arrests inflammation in humans with the mutation.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15030767 DOI: 10.1016/s1074-7613(04)00055-x
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745